Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing?

    April 2018 in “ JAMA Dermatology ”
    Ralph M. Trüeb
    Studysummary This abstract provided no research findings as it contains only website navigation and service information.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jamanetwork.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Aromatase Inhibitor Therapy and Hair Loss Among Breast Cancer Survivors Breast Cancer Research and Treatment · 2013
    2. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013
    3. Efficacy and Tolerability of Two Scalp Cooling Systems for the Prevention of Alopecia Associated with Docetaxel Treatment Supportive Care in Cancer · 2013
    4. Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy by Sequential Fluorouracil/Epirubicin/Cyclophosphamide (FEC) and Docetaxel: A Prospective Study of 20 Patients Annals of Oncology · 2012
    5. Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases The American Journal of Dermatopathology · 2011
    6. Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned? Dermatology · 2007
    7. The Hair Follicle as an Estrogen Target and Source Endocrine Reviews · 2006
    8. Effects of Minoxidil 2% vs. Cyproterone Acetate Treatment on Female Androgenetic Alopecia: A Controlled, 12-Month Randomized Trial British Journal of Dermatology · 2002